Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
|Active Ingredient:||Nystatin 100000IU/mL|
|Dosage Form:||Oral drops|
|New Zealand Sponsor:||Devatis Limited|
|Manufacturer:||Deva Holding AS, Tekirdag, Turkey|
Dated this 24th day of May 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).